News

Sanofi-Regeneron's Dupixent gets FDA's nod for skin condition
The U.S. Food and Drug Administration approved the use of Sanofi and Regeneron's blockbuster drug Dupixent for patients with ...
Zacks Investment Research on MSN6h
Sanofi & Regeneron's Dupixent Receives FDA Nod for Urticaria
Sanofi SNY and partner Regeneron REGN announced that the FDA approved Dupixent (dupilumab) for the treatment of chronic ...
BioSpace7h
Following Rejection, FDA Okays Sanofi/Regeneron’s Dupixent for Chronic Hives
Dupixent, which was rejected by the FDA for chronic spontaneous urticaria in October 2023, is now approved as the first new ...
STAT6h
FDA approves blockbuster Dupixent for chronic hives
The FDA had rejected the companies’ initial application in 2023, requesting additional data after the pharma firms reported ...
Fierce Pharma3d
Sanofi, Regeneron score their 7th indication for Dupixent with FDA nod to treat hives condition
On its way to generating sales of $14 billion in just its seventh full year on the market, Sanofi and Regeneron’s Dupixent ...
pharmaphorum5h
Sanofi's Dupixent gets FDA nod for chronic hives indication
Sanofi and Regeneron's Dupixent (dupilumab) has been approved by the FDA for the treatment of chronic spontaneous urticaria ...
PharmExec10h
Sanofi Advances Mid- to Late-Stage Respiratory Pipeline, Targeting Unmet Need in Asthma, COPD
New Phase II data demonstrate amlitelimab’s efficacy in heterogeneous inflammatory asthma, as lunsekimig and itepekimab ...
Fierce Biotech4d
Sanofi pens $1.8B research deal for 2 bispecific antibodies aimed at autoimmune, immunology
Sanofi is continuing to splash the cash for autoimmune and immunology assets this spring by penning a new deal with ...
Medical Dialogues4h
FDA Approves Dupilumab as First New Targeted Therapy for Chronic Spontaneous Urticaria in Over a Decade
The US Food and Drug Administration (FDA) has approved dupilumab (Dupixent) for the treatment of chronic spontaneous ...
BioPharma Dive3d
Sanofi, Regeneron win FDA nod for Dupixent in chronic hives
The partners overcame an earlier rejection to win a seventh use for Dupixent, though some analysts are skeptical of its sales ...
TipRanks on MSN2d
Regeneron, Sanofi announce FDA approval of Dupixent for CSU
Regeneron Pharmaceuticals (REGN) and Sanofi (SNY) announced that the U.S. Food and Drug Administration has approved Dupixent ...
Reuters3d
Sanofi-Regeneron's Dupixent gets FDA's nod for skin condition
April 18 (Reuters) - The U.S. Food and Drug Administration approved the use of Sanofi (SASY.PA), opens new tab and Regeneron's (REGN.O), opens new tab blockbuster drug Dupixent for patients with a ...